Chemoinformaics analysis of Ethyl benzoylacetate
| Molecular Weight | 192.214 | nRot | 4 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 8 |
| Exact Molecular Weight | 192.079 | nRing | 1 |
| Solubility: LogS | -2.575 | nHRing | 0 |
| Solubility: LogP | 1.971 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 28.7775 |
| nHD | 0 | BPOL | 15.5105 |
| QED | 0.415 |
| Synth | 1.59 |
| Natural Product Likeliness | -0.216 |
| NR-PPAR-gamma | 0.061 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.425 |
| MDCK | 0.0000512 |
| BBB | 0.992 |
| PPB | 0.546085 |
| VDSS | 0.45 |
| FU | 0.329161 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.119 |
| CYP2c19-inh | 0.799 |
| CYP2c19-sub | 0.148 |
| CYP2c9-inh | 0.453 |
| CYP2c9-sub | 0.124 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.125 |
| CYP3a4-inh | 0.046 |
| CYP3a4-sub | 0.268 |
| CL | 10.199 |
| T12 | 0.86 |
| hERG | 0.155 |
| Ames | 0.133 |
| ROA | 0.273 |
| SkinSen | 0.798 |
| Carcinogencity | 0.344 |
| EI | 0.992 |
| Respiratory | 0.534 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.712822 |